Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study — Chikara Ogawa (2017) | RDL Network
Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study
Article 2017 en
Authors
CO
Chikara Ogawa
MM
Masahiro Morita
AO
Akina Omura
Abstract
1 min read
In sorafenib therapy, patients with HFS and those who received post-progression treatment exhibited good OS.
Clarence Yen, Ratnadeep Sharma, Lorenza Rimassa, T. Arizumi, D. Bettinger, Huay Yee Choo, Tiziana Pressiani, M.E. Burlone, M. Pirisi, Laura Giordano, Abdulkarim Abdulrahman, Masatoshi Kudo, Robert Thimme, J.W. Park, David J. Pinato
Clarence Yen, Rohini Sharma, Lorenza Rimassa, Tadaaki Arizumi, Dominik Bettinger, Huay Yee Choo, Tiziana Pressiani, Michela Emma Burlone, Mario Pirisi, Laura Giordano, Anisa Abdulrahman, Masatoshi Kudo, Robert Thimme, Joong Won Park, David J. Pinato
Jordi Bruix, Philippe Merle, Alessandro Granito, Yi‐Hsiang Huang, G. Bodoky, Osamu Yokosuka, Olivier Rosmorduc, В. В. Бредер, René Gerolami, Gianluca Masi, Paul J. Ross, Shukui Qin, Tianqiang Song, Jean‐Pierre Bronowicki, Isabelle Ollivier‐Hourmand, Masatoshi Kudo, Lei Xu, Annette Baumhauer, Gerold Meinhardt, Guohong Han
Discussion(0)
No comments yet. Be the first to comment.